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Abstract
Aim: The study aimed to explore the association between diabetes- related distress as 
a dependent variable and fear of hypoglycaemia as a independent variable in Chinese 
individuals with type 2 diabetes, which can provide a basis for the development of 
effective nursing interventions.
Design: A cross- sectional descriptive study.
Methods: Pre- piloted scales were used to determine whether they experienced fear 
of hypoglycaemia and whether this impacted upon their management of the disease. 
From June– October 2019, participants were asked to complete the “hypoglycae-
mia fear survey” and “diabetes distress scales” to assess levels of fear and distress. 
Stepwise multivariate regression analysis was applied to reveal relationship between 
distress as a dependent variable and fear as a independent variable. Covariates in-
cluded demographic, clinical or lifestyle factors.
Results: A total of 258 participants were recruited for the survey, and they were 
characterized by little or no distress (39.53%), moderate distress (45.35%) and high 
distress (15.12%). The prevalence of moderate to severe distress in patients was 
60.47%. Increased diabetes- related distress was strongly correlated with increased 
fear of hypoglycaemia and closely associated with the scores of the worry and behav-
iour subscales. These results indicated that 62.3% of diabetes- related distress may be 
explained by fear of hypoglycaemia.
Conclusion: Increased diabetes- related distress is associated with increased fear of 
hypoglycaemia in individuals with type 2 diabetes.
K E Y W O R D S
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1  | INTRODUC TION
Approximately 50% of patients with type 2 diabetes mellitus 
(T2DM) using glucose- lowering medications will experience ep-
isodes of hypoglycaemia each month, with 9% experiencing 
severe hypoglycaemia (Khunti et al., 2017). This is significant, 
because hypoglycaemia is associated with higher readmission 
rates and patient distress (Lipska et al., 2014). Hypoglycaemia 
is a major concern with the management of diabetes. It not only 
hinders the achievement of optimal glycemic control but also 
leads to various sequelae, such as diabetes- related distress (DD) 
(Thanakwang et al., 2014) and impaired quality of life of pa-
tients (Janice et al., 2014). Furthermore, it can be life threatening 
(Hsu et al., 2013; Leiter et al., 2014; Orozco- Beltran et al., 2018; 
Seaquist et al., 2013).
The potential for sudden, unpredictable and uncomfortable 
symptoms for those patients with type 2 diabetes can lead to “fear of 
hypoglycaemia” (FOH) in some (Orozco- Beltran et al., 2018). There 
is a wide range of literature linking increased FOH with poor self- 
management behaviours in patients with type 2 diabetes, such as 
excessive diet control and compulsive monitoring of glucose levels, 
cause negative impact on disease management (Leiter et al., 2014; 
Orozco- Beltran et al., 2018; Seaquist et al., 2013). The incidence 
of DD is 18%– 45% and is higher in women than in men (Forsander 
et al., 2017; Hsu et al., 2013). One study (Martyn- Nemeth et al., 2014) 
indicated that there was a non- linear relationship between DD and 
FOH in participants with type 1 diabetes mellitus (T1DM). However, 
little is known about the correlation between these factors in par-
ticipants with T2DM. This study investigates FOH and DD to review 
the relationships between DD and FOH in T2DM.
1.1 | Background
Hypoglycaemia refers to the blood sugar level of <4 mmol/L that 
is prone to sudden onset and unpleasant or uncomfortable physi-
cal and psychological reactions, such as dizziness, fatigue, sweat-
ing, mental disorder and irritability (Orozco- Beltran et al., 2018). 
However, not all hypoglycaemic episodes are detected— as they may 
be asymptomatic until they reach severe status. This unpredictabil-
ity increases the difficulty of identifying and treating hypoglycaemia 
(Leiter et al., 2014; Orozco- Beltran et al., 2018; Seaquist et al., 2013). 
Mild hypoglycaemia is a symptom that patients can deal with on 
their own, while severe hypoglycaemia requires assistance from 
healthcare providers (Ng et al., 2019). Severe hypoglycaemia is com-
mon in individuals with diabetes receiving insulin, and this regularly 
causes distress in patients with type 1 diabetes (Inkster et al., 2012).
DD is the recurring experience of negative emotions in patients 
with diabetes. It causes adverse emotional reactions in patients 
and affects disease management, emotional burden and treatment 
(Thanakwang et al., 2014). In China, the prevalence of moderate or 
severe DD in patients can be as high as 42.15% (Zhou et al., 2017). 
These results are similar to the multinational “DAWN” trial results, 
which identified DD in 45% of participants and concluded that di-
abetes negatively impacted on their general well- being. (Nicolucci 
et al., 2013). Other factors such as gender, age, marital status, edu-
cation level, the course of disease and complications in patients are 
linked with DD (Fisher et al., 2015; Zhou et al., 2017).
DD not only interferes with patient self- management 
(Aikens, 2012), but it also negatively impacts treatment compliance 
(Zhang et al., 2013). This has clinical implications as well, because 
studies link high levels of DD with higher HbA1c measures (Hessler 
et al., 2014, 2017; Martyn- Nemeth et al., 2014). High levels of emo-
tional burden and regimen- related distress are also associated with 
higher HbA1c results (Peyrot et al., 2008). Thus, DD and emotional 
burden can lead to unstable glycemic control and poor disease man-
agement. This is cyclical, because lack of glucose level control is 
one of the main sources of distress (Tanenbaum et al., 2016), which 
threatens physical and mental health and well- being. Therefore, the 
early screening of the psychological state of patients with diabetes 
is very important.
There are very few studies on FOH and DD in populations with 
T2DM. Most studies are limited to the analysis of the current sit-
uation and influencing factors. One of the sources of distress in 
patients with diabetes is hypoglycaemia (Fisher et al., 2015; Karter 
et al., 2010), but studies of the relationship between FOH and DD 
are scarce. There is a gender difference; one study showed FOH and 
DD levels in women were twice as high as those in men (Forsander 
et al., 2017); however, the link between FOH and DD was not ex-
plored. One study identified a non- linear relationship between 
diabetes- related interpersonal distress and the FOH behaviours in 
participants with T1DM (Martyn- Nemeth et al., 2014). However, 
these factors have not yet been investigated in populations with 
T2DM. It is important to identify levels of stress in patients, so that 
healthcare professionals can provide adequate, evidence- based sup-
port and treatment to reduce DD and FOH in populations with all 
types of diabetes. Improving patients' psychological states can opti-
mize disease management and nurses have a significant role in this.
1.2 | Research questions
1. What is the current status of DD in patients with T2DM?
2. Are there any differences in demographic characteristics, clinical 
characteristics and FOH among patients with different levels of 
DD?




To explore the association between DD and FOH in patients with 
T2DM.
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2.2 | Design
A cross- sectional descriptive study of clinical and survey data from 
patients with type 2 diabetes who attend healthcare centres and 
hospitals across the Jiangsu Province of China. The study was con-
ducted using the Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE) guideline for cross- sectional 
studies (von Elm et al., 2008) (Appendix S1).
2.3 | Study participants
Participants were invited to take the survey and drawn from endocri-
nology departments across 3 tertiary general hospitals in Yangzhou 
and Suzhou. The inclusion criteria were as follows: participants with 
confirmed T2DM (WHO, 2006); participants with a duration of T2DM 
of at least 1 year who experienced hypoglycaemia in the past half- year; 
and participants aged 18 years or older. The exclusion criteria included 
the following: patients diagnosed with T1DM, pregnancy, psychosis or 
other serious disease (i.e. cancer); serious complications such as myo-
cardial infarction; patients with communication barriers; and patients 
who were unwilling to participate in this study. All participants agreed 
to complete our questionnaire, with clinical and demographic data 
linked through hospital electronic records.
2.4 | Sampling
Cluster random sampling was conducted from June– October in 2019. 
All participants were invited from three endocrinology departments 
across three tertiary general hospitals in Yangzhou and Suzhou, 
Jiangsu Province, China. Sample size was determined by 18% pro-
portion of DD in T2DM (Association Diabetes Association, 2014), 
with a 95% confidence level and 5% margin of error. We used the 
formula - N = Z2 × (P × (1 − P))/E2 to calculate it. By adding 10% non- 
response rate, the total sample size was 250. Our sample size had 
met the requirements (258 > 250).
2.5 | Data collection
After obtaining permission from the relevant departments of the 
hospital, four researchers conducted investigations in the endocri-
nology department. The researchers explained the purpose of the 
study to the inpatients and invited them to complete a survey of 
general and clinical characteristics, FOH and DD on site after ob-
taining informed consent and signing. Participants were asked to 
complete surveys in the clinical institution while in the waiting area. 
All responses were anonymous and completed surveys kept in in-
dividual, sealed envelopes with no identifying features. For illiter-
ates who agreed to participate in the study, they were asked to press 
their fingerprints at the signature of the informed consent form. 
The researchers read all the questions to them and recorded the 
answers. General and clinical characteristics of participants such as 
age, gender, body mass index (BMI), smoking, alcohol use and HbA1c 
were obtained from electronic medical records. Diet, exercise and 
frequency of hypoglycaemia were determined by self- reporting. All 
participants completed the questionnaires independently under the 
guidance of the researchers.
2.6 | Ethical considerations
The study was approved by the Ethics Committee of the university 
and the affiliated hospital (2019- YKL05- 30), and informed consent 
was obtained from all participants.
2.7 | Validity and reliability
2.7.1 | Fear of hypoglycaemia
The Chinese version of the Hypoglycemia Fear Survey II (HFS- II) was 
developed by Cox (Cox et al., 1987), and the updated version was 
published in 2011 (Gonder- Frederick et al., 2011). It was translated 
into Chinese by Mu (Mu, 2015). It is a 5- point Likert scale consisting 
of an 18- item Chinese version of the Hypoglycemia Fear Survey II- 
worry scale (CHFSII- WS) and a 15- item behaviour scale (CHFSII- BS). 
The worry scale reflects fears or worries about hypoglycaemia of pa-
tients, and the behaviour subscale contains behaviours that people 
use to avoid hypoglycaemia. The scores of the HFS- II, CHFSII- WS 
and CHFSII- BS ranged from 0– 132, 0– 72 and 0– 60, respectively. 
High scores indicate a high level of fear. Cronbach's alpha values of 
the HFS- II, CHFSII- WS and CHFSII- BS are 0.94, 0.90 and 0.88, re-
spectively, for Chinese participants.
2.7.2 | Diabetes- related distress
The Chinese version of the Diabetes Distress Scale (DDS) measures 
emotional burden, physician- related distress, regimen- related dis-
tress and diabetes- related interpersonal distress, and it was devel-
oped by Polonsky (Polonsky et al., 2005) and translated into Chinese 
by Yang (Yang & Liu, 2010). It is a 6- point Likert scale with 17 items; 
Cronbach's alpha value is 0.95 for Chinese participants. The higher 
the total score, the greater the distress is. According to Fisher's sug-
gestion (Fisher et al., 2012), we divided the DDS into three levels 
based on the average score (little or no distress, <2.0; moderate dis-
tress, 2.0– 2.9; high level of distress, ≥3.0). DD was considered clini-
cally significant if the average score was ≥2.0.
2.8 | Data analysis
Data were collated and analysed using SPSS 21.0 (SPSS Inc., 
Chicago, IL, USA). Categorical variables were summarized using 
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frequency distributions. Categorical variables between group dif-
ferences were evaluated by a chi- square test to reveal any associa-
tions with levels of DD. The mean and standard deviation (SD) were 
used to describe the continuous variables. Continuous variables 
that were normally and non- normally distributed were assessed by 
ANOVA and the Kruskal– Wallis test, respectively. The correlations 
between the FOH and DD scores were examined using Spearman's 
correlation coefficients. Stepwise multivariate regression analysis 
was used to determine correlations between behavioural scores 
using FOH and DD scales. A statistically significant difference was 
indicated by p < .05.
3  | RESULTS
3.1 | General and clinical characteristics of 
participants (N = 258)
A total of 286 questionnaires were sent out, 258 of which were 
valid, offering a response rate of 90%. Participants were grouped 
into (Fisher et al., 2012) levels consisting of “little or no distress” 
(N = 102), “moderate distress” (N = 117) and “high level of distress” 
(N = 39). The prevalence of moderate to severe DD in patients was 
60.47%. Demographic results are presented across these three 
groups.
A chi- square test for independence with the Yates continuity 
correction indicated no significant differences for gender, 
lifestyle and education levels— Table 1 shows spread in age, gen-
der, BMI and lifestyle between groups was equally dispersed. 
ANOVA test between groups analysis of variance illustrated no 
statistically significant differences in mean scores between mean 
scores for age and BMI across groups. The mean age and BMI for 
the full group was 61.98 years (SD 12.69) and 23.78 kg/m2 (SD 
3.39). Less than 15% participants were identified as illiterate. Most 
participants had completed basic education and very few lived 
alone.
Table 2 shows clinical characteristics, again, across the three 
DD groups. More than half the total participants had been diag-
nosed for over 10 years. Those in moderate or higher levels of 
distress groups reported insulin use as adjunct to treatment. 
Most participants had little or no family history of diabetes 
(N = 199/258). In all groups, most had reported complications of 
their diabetes status (N = 163/258). Many participants reported 
regularly exercising (N = 174/258). Only 30% reported smoking 
and under 30% reported ingesting alcohol on a regular basis. 
Most participants performed regular blood glucose monitoring 
(N = 237/258).
Participants who had experienced hypoglycaemia episodes more 
than three times in the past 6 months, and those experiencing hy-
poglycaemia overnight, were more likely to report higher levels of 
DD and fall within the “moderate to high distress groups” (p < .001). 
Those who had experience of severe hypoglycaemia also reported 
higher levels of DD (p = .001). In all groups, although the majority of 
patients with HbA1c more than 7%, there was no statistically signif-
icant difference (p = .495).
3.2 | Survey and scale characteristics of participants 
(N = 258)
We performed ANOVA and the Kruskal– Wallis test to test for dif-
ferences among the three groups according to their levels of distress 
in the HFS- II score. Table 3 presents mean scores from the hypo-
glycaemia fear, behaviour and worry scales. The S- N- K method was 
performed following the ANOVA test, and a statistical difference 
was noted between groups and mean scores suggest those in the 
TA B L E  1   Demographic characteristics
Demographic characteristics Diabetes distress group
pTotal N = 258






Age (years) Mean age (61.98 SD 12.69) 62.59 (SD 10.74) 62.56 (SD 13.17) 58.64 (SD 15.48) .205
Gender Male (N = 126) 51 (50.0%) 55 (47.0%) 20 (51.3%) .859
Female (N = 132) 51 (50.0%) 62 (53.0%) 19 (48.7%)
BMI (kg/m2) Mean BMI (23.78 SD 3.39) 23.96 (SD 2.81) 23.20 (SD 2.70) 23.06 (SD 4.15) .351
Lifestyle and 
education
Living alone (N = 28) 14 (13.7%) 11 (9.4%) 3 (7.7%) .544
Illiteracy (N = 37) 15 (14.7%) 18 (15.4%) 4 (10.3%) .621
Basic education ≤ high school 
(N = 183)
74 (72.6%) 79 (67.5%) 30 (76.9%)
Tertiary education > high 
school (N = 38)
13 (12.7%) 20 (17.1%) 5 (12.8%)
Note: ANOVA and the chi- square test were used to test for differences in the age, BMI, gender, lifestyle and education among the three groups 
according to their levels of distress.
Abbreviations: BMI, body mass index; SD, standard deviation.
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moderate and higher distress groups experienced higher levels of 
DD (p < .001)— depicted through behaviour, fear and worry about 
their diabetes management.
3.3 | Correlation between DD and FOH
To determine the strength and linear relationship between DD and 
FOH, Spearman's product– moment correlation coefficient was ap-
plied (the data of DDS were non- normal.). Table 4 shows a strong, 
positive correlation between the scores of DDS and HFS- II (r = .749, 
p < .001). The CHFSII- BS score also revealed a positive relation-
ship between behaviours and DD (r = .597, p < .001). Equally, the 
CHFSII- WS score revealed strong and positive relationship between 
worry and DD (r = .750, p < .001). These results indicated that DD is 
strongly associated with fear, worry and behaviours in T2DM.
3.4 | Association between DD and FOH
Table 5 shows that stepwise multivariate regression analysis was 
applied to assess correlations between DD as a dependent vari-
able and FOH as a independent variable. Covariates included de-
mographic, clinical or lifestyle factors. The square root of the 
DDS score was normal, although the initial data were not nor-
mally distributed. The HFS- II, CHFSII- WS and CHFSII- BS scores 
TA B L E  2   Clinical characteristics
Clinical characteristics
Total N = 258
Diabetes distress group
p






Duration type 2 Diabetes diagnosis <10 years 
(N = 111)
41 (40.2%) 55 (47.0%) 15 (38.5%) .491
>10 years 
(N = 147)
61 (59.8%) 62 (53.0%) 24 (61.5%)
Insulin use Y (N = 148) 49 (48.5%) 70 (59.8%) 29 (74.4%) .017
N (N = 110) 53 (51.5%) 47 (40.2%) 10 (25.6%)
Family history (diabetes mellitus) Y (N = 59) 23 (22.5%) 27 (23.1%) 9 (23.1%) .995
N (N = 199) 79 (77.5%) 90 (84.1%) 30 (76.9%)
Past history Y (N = 179) 79 (77.5%) 75 (64.1%) 25 (64.1%) .075
N (N = 79) 23 (22.5%) 42 (35.9%) 14 (35.9%)
Complications associated with 
diabetes
Y (N = 163) 68 (66.7%) 64 (54.7%) 31 (79.5%) .014
N (N = 95) 34 (33.3%) 53 (45.3%) 8 (20.5%)
Lifestyle
Diet control
Y (N = 215) 94 (92.2%) 85 (72.6%) 36 (92.3%) <.001
N (N = 43) 8 (7.8%) 32 (27.4%) 3 (7.7%)
Lifestyle
Exercise
Y (N = 174) 75 (73.5%) 72 (61.5%) 27 (69.2%) .162
N (N = 84) 27 (26.5%) 45 (38.5%) 12 (30.8%)
Lifestyle
Smoking
Y (N = 76) 32 (31.4%) 30 (25.6%) 14 (35.9%) .411
N (N = 182) 70 (68.6%) 87 (74.4%) 25 (64.1%)
Lifestyle
Alcohol use
Y (N = 69) 28(27.5%) 30 (25.6%) 11 (28.2%) .932
N (N = 263) 74 (72.5%) 87 (74.4%) 28 (71.8%)
Self- monitoring of blood glucose Y (N = 237) 96 (94.1%) 103 (88.0%) 38 (97.4%) .137
N (N = 21) 6 (5.9%) 14 (12.0%) 1 (2.6%)
Frequency of hypoglycaemia in the 
past half- year (≥3 times)
Y (N = 111) 20 (19.6%) 59 (50.4%) 32 (82.1%) <.001
N (N = 147) 82 (80.4%) 58 (49.6%) 7 (17.9%)
Experience of hypoglycaemia at 
night
Y (N = 76) 20 (19.6%) 30 (25.6%) 26 (66.7%) <.001
N (N = 182) 82 (80.4%) 87 (74.4%) 13 (33.3%)
Experience of severe 
hypoglycaemia
Y (N = 32) 5 (4.9%) 16 (13.7%) 11 (28.2%) .001
N (N = 226) 97 (95.1%) 101 (86.3%) 28 (71.8%)
HbA1c (≥7.0%) Y (N = 206) 78 (76.5%) 95 (81.2%) 33 (84.6%) .495
N (N = 52) 24 (23.5%) 22 (18.8%) 6 (15.4%)
Note: The chi- square test was used to test for differences in the variables listed above among the three groups according to their levels of distress.
Abbreviations: N, No; Y, Yes.
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were analysed in quartiles during the linear regression analyses. 
Preliminary analyses were undertaken to ensure there were no vio-
lations of the assumptions of homoscedasticity, multicollinearity, 
normality and linearity.
The levels for the HFS- II score were as follows: 1st quartile (≤27), 
2nd quartile (28– 35), 3rd quartile (36– 47) and 4th quartile (≥48). The 
levels of the CHFSII- WS score were as follows: 1st quartile (≤11), 
2nd quartile (12– 14), 3rd quartile (15– 20) and 4th quartile (≥21). The 
levels of the CHFSII- BS score were as follows: 1st quartile (≤15), 2nd 
quartile (16– 21), 3rd quartile (22– 27) and 4th quartile (≥28). Model 
1 showed that the DDS score was associated with the scores of 
HFS- II (β = 0.825, p < .001), CHFSII- WS (β = 0.794, p < .001) and 
CHFSII- BS (β = 0.678, p < .001). After adjusting for age, gender, BMI, 
lifestyle and education, duration, family history, past history, exer-
cise, smoking, alcohol use, self- monitoring of glucose and HbA1c, 
Model 2 showed that the DDS score was associated with the scores 
of HFS- II (β = 0.879, p < .001), CHFSII- WS (β = 0.802, p < .001) and 
CHFSII- BS (β = 0.723, p < .001). Model 3, after adjusting for the 
13 independent variables included in Model 2 and the 9 statistically 
significant independent variables listed in Tables 1- 3, showed that 
patients in the 4th quartile of the scores of HFS- II, CHFSII- WS and 
CHFSII- BS were more likely to have a higher DDS score (HFS- II: 
β = 0.753, p < .001; CHFSII- WS: β = 0.675, p < .001; and CHFSII- BS: 
β = 0.534, p < .001). The adjusted R2 of three models were 62.3% 
(HFS- II), 57.2% (CHFSII- WS) and 46.4% (CHFSII- BS), respectively. 
These results indicated almost that over 50% of DD may be ex-
plained by FOH (p < .01) and a higher DD score may be associated 
with higher FOH scores.
4  | DISCUSSION
We explored the relationship between DD and FOH in patients with 
T2DM. The results indicate that after adjusting for confounding 
factors, DD expresses a significant association with FOH and the 
higher the FOH score, the greater the DD score was. Given the few 
studies on the relationship between FOH and DD, our results may 
not be representative of the whole world. However, the presence 
of FOH and DD in patients with T2DM is common in other regions. 
Therefore, our results have some reference values.
This matters to multidisciplinary care and support networks 
offered to patients with T2DM. By understanding how and why 
patients may feel ill at ease, and offering appropriate dietary and 
lifestyle advice, patients can understand and navigate their own 
health journeys with diabetes. Our findings offer an intelligence and 
evidence base for patient support and guidance which focuses on 
Diabetes distress group
p






HFS- II (mean 
[SD])
26.67 (6.44) 40.30 (10.76) 57.59 (11.96) <.001
CHFSII- BS 
(mean [SD])
16.91 (5.85) 23.09 (7.68) 30.21 (6.14) <.001
CHFSII- WS 
(mean [SD])
10.75 (2.96) 17.33 (5.59) 27.38 (9.14) <.001
Note: ANOVA and the Kruskal– Wallis test were used to test for differences in the HFS- II, 
CHFSII- BS and CHFSII- WS scores among the three groups according to their levels of distress.
Abbreviations: CHFSII- BS, behaviour scale; CHFSII- WS, worry scale; HFS- II, Hypoglycaemia Fear 
Survey II; SD, standard deviation.
TA B L E  3   Survey and scale 
characteristics
DDS
HFS- II CHFSII- BS CHFSII- WS
r p r p r p
Total score .749 <.001 .597 <.001 .750 <.001
Emotional burden .743 <.001 .614 <.001 .712 <.001
Physician- related distress .507 <.001 .404 <.001 .508 <.001
Regimen- related distress .533 <.001 .395 <.001 .572 <.001
Diabetes- related 
interpersonal distress
.608 <.001 .508 <.001 .585 <.001
Note: Spearman's correlation coefficients were used to examine the correlations between FOH and 
DD.
Abbreviations: CHFSII- BS, behaviour scale; CHFSII- WS, worry scale; DD, diabetes- related distress; 
DDS, the Diabetes Distress Scale; FOH, fear of hypoglycaemia; HFS- II, Hypoglycaemia Fear Survey 
II.
TA B L E  4   The correlation between 
FOH and DD
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FOH. To help patients manage their disease, the multidisciplinary 
team need to identify factors associated with distress and fear in 
their patients.
DD is not only common in T1DM patients (Hagger et al., 2016) 
but also common in T2DM patients (Owens- Gary et al., 2019; Snoek 
et al., 2015). If we consider T1DM, there may be other confounding 
variables to be considered. For example, some studies have linked 
female gender, lack of home support, increasingly complex treat-
ment regimes, complications of diabetes and lack of activity as con-
founding factors in DD (Fonda et al., 2009; Forsander et al., 2017; 
Ting et al., 2011).
Our findings indicated that nearly 60.47% of participants self- 
reported moderate to severe distress— a rate far higher than that 
observed by Zhou et al., (2017). This may be because our study also 
included data on T2DM who had used insulin or had experienced 
hypoglycaemia within 6 months of investigation. This is important 
to note, because fear of hypoglycaemia can lead to DD in patients 
(Fisher et al., 2015; Karter et al., 2010).
Evidence suggests that patients with a high degree of DD have 
poor self- management, such as an irregular dietary pattern and moni-
toring of glucose levels, which leads to more frequent hypoglycaemia 
(Al Sayah et al., 2019; Kostev et al., 2014). Our study found that pa-
tients with hypoglycaemia are more prone to FOH. The higher the FOH 
score, the greater the DD score. Thus, a vicious circle of fear– worry 
and exacerbation can seriously damage the physical and mental health 
status of patients, hindering disease management. This is why the full 
multidisciplinary team should be included in management strategies.
Patients with frequent hypoglycaemia tend to have FOH, which 
is not conducive to psychological well- being and stable glycemic 
control. Poor disease management will also increase the psycholog-
ical burden of patients. Thus, it is very important to take psycholog-
ical screening and health education seriously in the early stage of 
hypoglycaemia. Healthcare providers should encourage patients to 
express their inner thoughts and assist patients in solving problems 
related to disease, standardizing their self- care behaviours, and re-
ducing FOH, thus alleviating DD.
TA B L E  5   Multiple regression analyses of the correlation between FOH and DD
Model 1 Model 2 Model 3
β 95% CI p β 95% CI p β 95% CI p
HFS- II
1st 1 1 1
2nd 0.096 −0.009 to 0.407 .061 0.100 0.000– 0.413 .050 0.063 −0.072 to 0.334 .205
3rd 0.435 0.696– 1.114 <.001 0.469 0.767– 1.185 <.001 0.364 0.538– 0.975 <.001
4th 0.825 1.525– 1.947 <.001 0.879 1.636– 2.063 <.001 0.753 1.346– 1.818 <.001
AdjR2 0.556 0.588 0.623
F 108.42 <.001 22.586 <.001 19.378 <.01
WS
1st 1 1 1
2nd 0.140 0.093– 0.528 .005 0.149 0.108– 0.552 .004 0.118 0.047– 0.482 .018
3rd 0.519 0.853– 1.258 <.001 0.546 0.900– 1.319 <.001 0.462 0.715– 1.160 <.001
4th 0.794 1.496– 1.921 <.001 0.802 1.508– 1.943 <.001 0.675 1.208– 1.696 <.001
AdjR2 0.532 0.537 0.572
F 98.568 <.001 18.558 <.001 15.899 <.01
BS
1st 1 1 1
2nd 0.117 −0.01 to 0.488 .061 0.112 −0.025 to 0.483 .077 0.037 −0.166 to 0.318 .535
3rd 0.337 0.454– 0.964 <.001 0.402 0.579– 1.110 <.001 0.265 0.296– 0.817 <.001
4th 0.678 1.177– 1.689 <.001 0.723 1.261– 1.796 <.001 0.534 0.852– 1.405 <.001
AdjR2 0.352 0.372 0.464
F 47.522 <.001 9.945 <.001 10.652 <.01
Note: 1st, 2nd, 3rd and 4th are the quartile scores of the questionnaires. The levels for the HFS- II score were as follows: 1st quartile (≤27), 2nd 
quartile (28– 35), 3rd quartile (36– 47) and 4th quartile (≥48). The levels of the WS score were as follows: 1st quartile (≤11), 2nd quartile (12– 14), 3rd 
quartile (15– 20) and 4th quartile (≥21). The levels of the BS score were as follows: 1st quartile (≤15), 2nd quartile (16– 21), 3rd quartile (22– 27) and 4th 
quartile (≥28). AdjR2 = adjusted R2. Model 1, unadjusted; Model 2, adjusted for age, gender, BMI, lifestyle and education, duration, family history, past 
history, exercise, smoking, alcohol use, self- monitoring of glucose levels and HbA1c; Model 3, adjusted for the 13 independent variables included in 
Model 2 and the 9 statistically significant independent variables listed in Tables 1- 3.
Abbreviations: BS, behaviour scale; DD, diabetes- related distress; FOH, fear of hypoglycaemia; HFS- II, Hypoglycaemia Fear Survey II; WS, worry 
scale.
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A previous study (Martyn- Nemeth et al., 2014) indicated that 
there was a non- linear relationship between the scores of diabetes- 
related interpersonal distress and the behaviour subscale for pa-
tients with T1DM. However, our study correlated DDS scores with 
the HFS- II score (r = .749, p < .001), and the score of diabetes- related 
interpersonal distress explained over 50% of behaviour and worry 
in DD (r = .508, p < .001) (r = .585, p < .001) Emotional burden also 
highly correlated with the total FOH score (r = .743, p < .001), espe-
cially with the worry subscale score (r = .712, p < .001). Emotional 
burden can limit the self- care behaviours and self- management of 
patients, which is not conducive to effective disease management 
(Aikens, 2012). Individuals with diabetes believe that knowledge 
and support from healthcare providers are important for their self- 
management and physical and mental health (Balfe et al., 2013). 
During the investigation, we found that the distress of patients who 
experienced hypoglycaemia partly came from a misunderstanding of 
the disease and the heavy burden of treatment regimens. Complex 
treatment regimens have strict standards for self- management 
behaviour, which easily leads to patient uncertainty (Gonzalez 
et al., 2015). Patients often do not understand why patients with 
diabetes suffer from hypoglycaemia, which easily results in FOH and 
poor glycemic control. This helps to explain the results of this study, 
which showed that both the physician- related distress and regimen- 
related distress scores were moderately correlated with the HFS- II 
score (r = .507, p < .001; r = .533, p < .001). Misunderstanding or 
uncertainty about the disease, including treatment adherence, and 
a high FOH score may cause an increased burden in terms of emo-
tion related to both the physician and the regimen. It is clear that 
increased DD is associated with increased FOH. Clinicians should 
pay greater attention to early psychological screening and health ed-
ucation, explain the process of treatment to patients and objectively 
assess whether patients understand the relevant knowledge to en-
sure that they can prevent, treat and manage their disease correctly 
to reduce FOH, thus alleviating DD and improving the quality of life 
in patients.
In summary, we suspected that the most fundamental cause of 
patient DD may be the misperception of disease- related knowledge 
among patients we surveyed and we will further confirm it in future 
research. The lack of knowledge causes self- management and self- 
care behaviours to become unreasonable, which leads to poor gly-
cemic control and frequent hypoglycaemia. It is easy to cause FOH, 
which aggravates DD. DD negatively affects physical and mental 
health, leading to an increased risk of hypoglycaemia (Al Sayah 
et al., 2019), and this eventually leads to a vicious circle. Therefore, 
correcting the patient's misperception of the disease is one of the 
important prerequisites to alleviate FOH and ultimately reduce DD.
The study showed that DD is positively correlated with FOH in 
T2DM patients and reveals “FOH” as a factor in DD. This result is 
rarely reported in previous studies. It also highlights the need for 
nurses to improve education for patients so that they can manage 
“hypoglycaemia” effectively. Firstly, practitioners need to assess 
their patients to assess for the presence of FOH and— if present— 
how debilitating it is for them. If this is a problem, then strategies to 
address it should be explored— these may simply involve reassurance 
or moderation of self- management practices— but in severe cases 
psychological intervention may be required. Close team working 
with clinical psychology members of the multi- disciplinary team is 
helpful in this scenario of diabetes care. Strong professional collab-
oration is one of the foundations for providing good nursing care. 
Healthcare providers should make serious effort to educate patients 
about hypoglycaemia and to conduct psychological screening of pa-
tients to develop effective nursing interventions to alleviate FOH 
and DD in individuals with T2DM, which can improve their quality 
of life.
4.1 | Limitations
The study does have limitations, in that it presents data from just 
one province of China which has a population of 80 million. Although 
population levels are high, there may be a cultural element to ex-
periences in diabetes management and self- care. Further studies 
are therefore recommended to identify any confounding variables 
which may impact populations in other countries and healthcare 
systems. In addition, incidents of hypoglycaemia were assessed ac-
cording to the patient's recollection, which inevitably might lead to 
recall errors. Therefore, it is necessary to expand the sample size 
and further explore the mechanism of the interaction between FOH 
and DD to provide a basis for developing a reasonable intervention 
strategy in the future.
5  | CONCLUSION
Increased DD is related to increased FOH in Chinese participants 
with T2DM. Healthcare providers should make serious effort to 
educate patients about hypoglycaemia and to conduct psychologi-
cal screening of patients to develop effective intervention measures 
to alleviate FOH and ultimately reduce DD in patients, which can 
improve their quality of life.
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